$APYX News

Last published 1w ago

1w agoAPYXApyx Medical Corp - EXHIBIT 99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
1w agoAPYXApyx Medical Corporation Reports Third Quarter 2026 Financial ResultsGlobeNewswireReported total revenue of $14.0 million in the third quarter of 2026 driven by 17% growth in the Surgical Aesthetics segmentInitiated successful full commercial launch of the power liposuction handpiece for the AYON
3w agoAPYXApyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026GlobeNewswireCLEARWATER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the
3w agoAPYXApyx Medical Corporation to Participate in Upcoming Investor ConferencesGlobeNewswireCLEARWATER, Fla., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON
3mo agoAPYXApyx Medical Corporation Reports Second Quarter 2026 Financial ResultsGlobeNewswireReported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece for the AYON platform
3mo agoAPYXApyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth ConferenceGlobeNewswireCLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the the leader in surgical aesthetics marketed and sold as Renuvion® and the
3mo agoAPYXApyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026GlobeNewswireCLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the
5mo agoAPYXBody by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the RunwayPR NewswireApyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the...
5mo agoAPYXNew Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®GlobeNewswireCLEARWATER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON
6mo agoAPYXApyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with LiposuctionGlobeNewswireCLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
6mo agoAPYXApyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™GlobeNewswireCLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON
6mo agoAPYXApyx Medical Corporation Reports First Quarter 2026 Financial ResultsGlobeNewswireReported total revenue of $12.5 million in the first quarter of 2026 primarily driven by 36% growth in the Surgical Aesthetics segmentRaised total revenue guidance for FY2026 to a range of $59.0 million to $60.0
6mo agoAPYXApyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026GlobeNewswireCLEARWATER, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
7mo agoAPYXRenuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"PR NewswireApyx Medical Corporation (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion™ and the...
8mo agoAPYXApyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireReported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System™ (AYON) to meet strong market demandExpect FY2026 total revenue in the
8mo agoAPYXApyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026GlobeNewswireCLEARWATER, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
8mo agoAPYXApyx Medical Corporation to Participate in The Citizens Life Sciences ConferenceGlobeNewswireCLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
9mo agoAPYXApyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewswireCLEARWATER, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
10mo agoAPYXApyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue ResultsGlobeNewswireCLEARWATER, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
11mo agoAPYXApyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South KoreaGlobeNewswireCLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
11mo agoAPYXApyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common StockGlobeNewswireCLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
11mo agoAPYXApyx Medical Corporation Announces Proposed Public Offering of Common StockGlobeNewswireCLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body
1y agoAPYXApyx Medical Corporation Reports Third Quarter 2025 Financial ResultsGlobeNewswireInitiated full U.S. commercial launch of AYON Body Contouring System™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectationsSubmitted new 510(k) for AYON for device label expansion to include
1y agoAPYXApyx Medical Corporation to Participate in Upcoming November Investor ConferencesGlobeNewswireCLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and
1y agoAPYXApyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025GlobeNewswireCLEARWATER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and
1y agoAPYXApyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power LiposuctionGlobeNewswireInitiated Nationwide Commercial Launch of AYON in September The Company is Hosting a Virtual Key Opinion Leader Event to Discuss the Commercial Launch of AYON on October 14, 2025 CLEARWATER, Fla., Oct. 13, 2025
1y agoAPYXApyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025GlobeNewswireCLEARWATER, Fla., Sept.
1y agoAPYXApyx Medical Corporation (APYX) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoAPYXApyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company") today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase
1y agoAPYXApyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated GrowthGlobeNewswireCLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion® and the newly launched AYON Body Contouring System™, today
1y agoAPYXApyx Medical Corporation Reports Second Quarter 2025 Financial ResultsGlobeNewswireSuccessfully launched AYON Body Contouring System™ to key surgeons in critical geographies; plan for commercial launch in September 2025Initiated commercial sales of Renuvion® in China with strong clinical
1y agoAPYXApyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth ConferenceGlobeNewswireCLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and
1y agoAPYXApyx Medical Corporation Announces Launch of Renuvion® in ChinaGlobeNewswireStrong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER, Fla., July 28,
1y agoAPYXApyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025GlobeNewswireCLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and
1y agoAPYXRenuvion® Brings Real Transformations to the Runway at Miami Swim WeekPR NewswireApyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the manufacturer of the proprietary helium plasma and radiofrequency...
1y agoAPYXApyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™GlobeNewswireThe AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion leader surgeons
1y agoAPYXApyx Medical Corporation Reports First Quarter 2025 Financial ResultsGlobeNewswireRevenue from the Advanced Energy segment increased 6% in Q1 2025 compared with the same period last yearU.S. single use handpiece revenue grew 14% in Q1 2025 compared with the same period last yearPreparing for a planned
1y agoAPYXRenuvion Introduces Television Star Dolores Catania as Chief of ConfidencePR NewswireApyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform...
1y agoAPYXApyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring ProceduresGlobeNewswireTwo studies report favorable clinical outcomes and safety data for Renuvion® when used during procedures that include lipoabdominoplasty for the treatment of loose and lax skin Rapid weight loss due to GLP-1 drugs
1y agoAPYXApyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025GlobeNewswireCLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and
1y agoAPYXRenuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"PR NewswireApyx Medical Corporation (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency...
1y agoAPYXApyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireThe number of single-use handpiece units shipped in Q4 2024 exceeded expectations, increasing 5% overall and 20% in the U.S. compared to the same period last yearSubmitted a 510(k) premarket notification to the U.S. FDA
1y agoAPYXApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025GlobeNewswireCLEARWATER, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed
1y agoAPYXApyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue ResultsGlobeNewswireCLEARWATER, Fla, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as
1y agoAPYXApyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™GlobeNewswireCLEARWATER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed
1y agoAPYXApyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswireCLEARWATER, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology
1y agoAPYXApyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select ConferenceGlobeNewswireCLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology
2y agoAPYXApyx Medical Corporation (APYX) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoAPYXApyx Medical Corporation Announces $7,000,000 Million Registered Direct OfferingGlobeNewswireCLEARWATER, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology
2y agoAPYXApyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial OutlookGlobeNewswireStrengthened balance sheet with a common stock registered direct offering with gross proceeds of approximately $7.0 million; and amended revenue covenants for the Company's credit agreement with PerceptiveAnnounces cost